MRNA

Disruptive Technology Channel

ETF Trends

Why Bill Gates Is Betting Millions on Synthetic Biology

By Special To ETF TrendsSeptember 12, 2020

Expert Insights

ETF Edge Tom Lydon Talks Tesla Snub By S&P 500

ETF Edge: Tom Lydon Talks Tesla Snub By S&P 500

By Aaron NeuwirthSeptember 10, 2020

Moderna Vaccine Optimism Could Drive Biotech ETFs

Moderna Vaccine Optimism Could Drive Biotech ETFs

By Ian YoungAugust 26, 2020

Nasdaq Portfolio Solutions Channel

A Power Pharmaceuticals ETF to Consider

A Power Pharmaceuticals ETF to Consider

By Tom LydonJuly 27, 2020

Biotech ETFs To Explore As Race For Covid-19 Vaccine Heats Up

Biotech ETFs To Explore As Race For Covid-19 Vaccine Heats Up

By Ian YoungJuly 22, 2020

Stock ETFs Struggle After Moderna Enthusiasm Fades

Stock ETFs Struggle After Moderna Enthusiasm Fades

By Ian YoungJuly 15, 2020

Moderna Study Sends Biotech ETFs And Stock Futures Surging

Moderna Study Sends Biotech ETFs And Stock Futures Surging

By Ian YoungJuly 14, 2020

Stock Index ETFs Jump After Holiday Weekend Amid Reopening Optimism

Stock Index ETFs Jump After Holiday Weekend Amid Reopening Optimism

By Ian YoungMay 26, 2020

Disruptive Technology Channel

This Is NOT 2008 All Over Again

By Special To ETF TrendsMay 23, 2020

AstraZeneca Joins Coronavirus Vaccine Race Making Biotech ETFs Potentially More Attractive

AstraZeneca Joins Coronavirus Vaccine Race, Great For Biotech ETFs

By Ian YoungMay 21, 2020

Stocks And Index ETFs Tumble Into Close Amid Revised Vaccine Considerations And Poor Economic Outlook

ETFs Tumble Into Close Amid Revised Vaccine Considerations And Poor Economic Outlook

By Ian YoungMay 19, 2020

Biotech ETFs Are Climbing As Moderna Builds Optimism For Coronavirus Vaccine

Biotech ETFs Climbing As Moderna Builds Hope For Coronavirus Vaccine

By Ian YoungMay 18, 2020